<DOC>
	<DOCNO>NCT02596126</DOCNO>
	<brief_summary>The purpose study evaluate efficacy polypill strategy contain aspirin ( 100 mg ) , ramipril ( 2.5 , 5 10 mg ) , atorvastatin ( 40 mg ) compare standard care ( usual care accord local clinical practice participate country ) secondary prevention major cardiovascular event ( cardiovascular death , nonfatal myocardial infarction , nonfatal ischemic stroke , urgent revascularization ) elderly patient recent myocardial infarction .</brief_summary>
	<brief_title>Secondary Prevention Cardiovascular Disease Elderly Trial</brief_title>
	<detailed_description>A total number 3206 patient randomize ( 1:1 ) treatment arm . Patients recruit across seven country Europe ( Spain , Italy , Germany , France , Hungary , Poland , Czech Republic ) . Patients ≥65 year old diagnose type 1 myocardial infarction within 8 week prior study enrolment . Once inclusion exclusion criterion confirm , patient include study signing inform consent . Randomization take place within 8 week index event ( AMI type I ) 1:1 ratio one two arm : - Cardiovascular Polypill ( contain Aspirin , Ramipril , Atorvastatin ) - Usual care Patients follow minimum 2 year maximum 4 year . There 3 follow visit month 6 , 12 24 telephone follow call month 18 , 36 48</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Ramipril</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>1 . Patients diagnose type 1 myocardial infarction within previous 8 week . 2 . Subjects must ≥65 year old , present least one follow additional condition : Documented diabetes mellitus previous treatment oral hypoglycemic drug insulin . Mild moderate renal dysfunction : creatinine clearance 6030 mL/min/1.73 m2 . Prior myocardial infarction : define AMI occur index event document medical report . Prior coronary revascularization : coronary artery bypass grafting ( CABG ) percutaneous coronary intervention ( PCI ) . Prior stroke : history document stroke , define acute episode focal cerebral , spinal , retinal dysfunction cause infarction central nervous system tissue , result death . Age ≥ 75 year . 3 . Signing informed consent . 1 . Unable sign inform consent . 2 . Contraindications component polypill . 3 . Living nursing home . 4 . Mental illness limit capacity selfcare . 5 . Participating another clinical trial . 6 . Severe congestive heart failure ( NYHA IIIIV ) . 7 . Severe renal disease ( Creatinine Clearance ( CrCl ) &lt; 30ml/min/1.73 m2 ) . 8 . Need oral anticoagulation time randomization plan future month . 9 . Any condition limit life expectancy &lt; 2 year , include limited active malignancy . 10 . Significant arrhythmia ( include unresolved ventricular arrhythmia atrial fibrillation ) . 11 . Scheduled coronary revascularization ( patient randomize final revascularization complete within prespecified timeframe ) . 12 . Do agree filing , forward use his/ pseudonymised data .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Polypill</keyword>
	<keyword>Prevention Secondary Cardiovascular Disease</keyword>
	<keyword>Cardiovascular Disease</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Cardiovascular Combination Polypill AAR</keyword>
	<keyword>Cardiovascular Disease Elderly</keyword>
	<keyword>Adherence</keyword>
	<keyword>SECURE</keyword>
	<keyword>Elderly</keyword>
	<keyword>Secondary Cardiovascular Disease</keyword>
	<keyword>Secondary Cardiovascular Prevention</keyword>
	<keyword>Randomized Cardiovascular Trial</keyword>
	<keyword>Randomized Trial</keyword>
	<keyword>Cardiovascular Polypill</keyword>
</DOC>